SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " bioscience " 53 found 🔀 AI-powered Shuffle
Sign in to save shuffle history.
Replicate Bioscience Appoints Kathy Fernando, Ph.D., as Chief Business Officer
/PRNewswire/ -- Replicate Bioscience, a clinical-stage company pioneering novel self-replicating RNA (srRNA) technology for applications across infectious...
IDEAYA Biosciences Provides a Business Update and Outlines 2026 Corporate Objectives at the 44th Annual J.P. Morgan Healthcare Conference
/PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a leading precision medicine oncology company, provided a business update including an overview of key...
Anthropic debuts Claude Science, an AI product for bioscience
On Tuesday, Anthropic announced Claude Science, a new product that company leaders describe as an AI workbench for scientific research.
Early-career scientists build national infrastructure to bridge science and policy
A new Special Report in the journal BioScience introduces the Scientist Network for Advancing Policy (SNAP), a student-led, nonpartisan, grassroots coalition founded in 2025 to empower early-career researchers ...
CBIH Announces Expanded Research Strategy at the Intersection of Endocannabinoid Science and Biological Medicine
Houston, Texas--(Newsfile Corp. - October 19, 2026) - Cannabis Bioscience International Holdings, Inc. (OTC Pink: CBIH), a public company trading on the OTC Markets under the ticker symbol CBIH, announced an expansion of its scientific research strategy focused on the intersection of endocannabinoid biology, precision medicine, and the development of intellectual property with potential biomedical applications."We are witnessing a new era in the history of medicine: an era in which human biology
At Family Science Night, Wonder Comes Before Answers.
BAR HARBOR—Family Science Night isn’t really about science. It’s about wonder. It’s about watching a five-year-old realize that the tiny creature under a microscope is a real living thing. It’s about a teenager discovering that the scientist explaining genetics or regeneration isn’t much older than they are. It’s about parents seeing curiosity spread across a child’s face the way excitement spreads across a crowd at a Fourth of July parade. For one evening, families realize that the laboratory isn’t some secretive place where knowledge is hidden behind white coats and closed doors. They learn that the lab is a place their neighbors work, their friends’ parents work, and it becomes a place where questions matter more than answers. It’s a place where wonder is the origin for knowledge. At the lab, children learn that it’s okay not to know. Adults remember that they once asked “Why?” about everything. Scientists are reminded why they fell in love with discovery in the first place. There are experiments, games, obstacle courses, and demonstrations, of course. But those are really just invitations—to touch, to explore, to laugh, to make mistakes, and to ask one more question. In a world that often rewards certainty, Family Science Night celebrates curiosity. And perhaps that’s its greatest gift. Long after the microscopes are packed away and the experiments are over, what families take home isn’t just a few new facts about biology. They take home the feeling that discovery belongs to everyone—that science isn’t something happening somewhere else by someone else. It’s simply what happens when people are given permission to wonder. A Family Science Night at the Mount Desert Island Biological Laboratory is one of those rare community events where children and adults can experience science as something they do, not just something they read about. Hands on discovery allows hands-on learning and joy. Real scientists, some local, some scientist-interns (but still scientists) just in college make science real, approachable, and exciting. And there, complex ideas like forever chemical-filtration, DNA and so much more become not complex. Instead, they become fun. Summer fellows are challenged to explain cutting-edge biomedical research in ways a first-grader—and their grandparent—can understand. Past activities have explored gene expression, kidney function, axolotl regeneration, worms, microplastics, and phytoplankton through games and creative demonstrations. Though it’s called family night, you can also see adults going from station to station, exploring, learning together across ages. Family Science Night reflects the laboratory’s broader mission of breaking down barriers between researchers and the public, helping people understand how scientific discoveries relate to everyday life and the health of Maine’s environment. Family Science Night transforms a world-class research laboratory into a giant interactive classroom, where curiosity is encouraged, questions are celebrated, and families discover that science isn’t just something that happens in a lab—it’s an adventure anyone can join. About MDI Biological Laboratory For more than 125 years, MDI Bio Lab has been a center for training and research in comparative biology. In the last two decades its biomedical research has focused on aging, regeneration, and environmental toxins. The Laboratory houses 11 research groups staffed by an international team of world-class scientists and graduate students. It also leads a statewide network of colleges, universities and research institutions that collaborate to provide training, research experiences and financial support to help young Mainers play a bigger role in today’s biomedical revolution. Located on Maine’s rugged coast, the Laboratory’s 100+ acre campus houses research facilities, cottages and dorms that house visiting scientists and students. It is also home to MDI Bioscience, a subsidiary working to design innovative techniques to speed the drug discovery process. LINKS TO LEARN MORE NIH INBRE MDI BIOLOGICAL LABORATORY Photos: Carrie Jones and Shaun Farrar/Bar Harbor Story HELP SUPPORT THE BAR HARBOR STORY When we started The Bar Harbor Story, we didn’t know if anyone would read it. But you showed up. You shared. You sent tips. Now—over 400,000 views every month later—it’s clear: people here care about their community and each other. We’ve kept everything free because news should never be out of reach, but every one of our stories takes time to write, and your support keeps The Bar Harbor Story going. If you value our work, please consider a paid subscription, a founding membership, or a sponsorship. It truly helps us cover one more meeting, tell one more story, shine one more light. Even $5 a month makes a difference. Click here to become a one-time supporter now. Thank you so much for being here. Founding member information can be found here. Have questions about sponsorships? Just send Shaun an email at sfarrar86@gmail.com, he’d love to hear from you. Subscribe Share Bar Harbor Story Share Leave a comment
Mosaic (MOS) Bets On Enzymes While Its Core Business Bleeds
On August 17, Mosaic Biosciences, a unit of The Mosaic Company (NYSE:MOS), launched Renuvis Enzara, an enzyme-based treatment meant to speed up how fast crop residue breaks down after harvest. The launch landed less than two weeks after Mosaic reported a second-quarter net loss of $273 million, a sharp reversal from the $411 million profit […]
BD Completes Combination of Biosciences & Diagnostic Solutions Business with Waters Corporation
FRANKLIN LAKES, N.J., Feb. 9, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX) today announced the successful completion of…...
GE HealthCare to buy Sofie Biosciences for $945 million to strengthen radiopharma business
Medical device maker GE HealthCare said on Monday it would buy privately held Sofie Biosciences for $945 million in cash, in a move that strengthens its ability to manufacture and distribute PET imaging drugs.
A Woolly Mouse Is Stealing Christmas Thanks To Science
Colossal Biosciences blends holiday cheer and genetic breakthroughs in a cozy new video starring a woolly mouse.
San Antonio eyes ‘City of Science’ future as bioscience sector looks to scale
San Antonio must boost bioscience marketing, investment and workforce to compete with biotech hubs like Dallas and Houston, leaders say.
UT Health San Antonio scientists honored with BioMedSA Innovation Awards
Two scientists at UT Health San Antonio, the academic health center of The University of Texas at San Antonio (UT San Antonio), will be honored with 2026 BioMedSA Innovation in Healthcare and Bioscience awards. The awards recognize San Antonio leaders in the areas of research, clinical innovation, entrepreneurship and lifetime achievement, whose accomplishments improve lives […]
Startup reveals ‘artificial egg’ to resurrect extinct birds, but scientists say the work misses the point
The science of de-extinction does not exist, but Colossal Bioscience’s “artificial egg” is an interesting technical feat
Turning rising gut health expectations into better health products
Written by Marcelo Durante, Sales & Marketing Director, Clasado Biosciences
UF opens Whitney Marine Research Center, expanding marine science innovation in St. Augustine
The University of Florida celebrated the opening of its new Whitney Marine Research Center on April 14, marking a significant expansion of marine science research, education and conservation efforts at the Whitney Laboratory for Marine Bioscience.
2026 State of the Climate Report Shows a Planet Reaching Its Limits
The seventh edition of an annual report analyzing Earth’s "planetary vital signs” indicates that Earth systems are rapidly destabilizing, some at an accelerating rate. The report, published today in BioScience, analyzed 16 of these signs, including greenhouse gas emissions levels, ocean heat content and acidity, the mass of major ice sheets, the number of hot days, Earth's surface temperature, and more.
Anixa Biosciences Appoints UPenn's Dr. Carmen Guerra to Cancer Business Advisory Board
/PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer,...
Neurocrine Biosciences to Present at the Bank of America Health Care Conference 2026
/PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that its executives will participate at the Bank of America Health Care Conference...
Form Bio: The Operating System for Science
Ben Lamm (left) and George Church (right) pose in front of a woolly mammoth. By Futurist Thomas Frey When Colossal Biosciences launched in 2021, one of the first things Ben Lamm did was sit down with his team and map out all the software they would need to actually do the work. The list came […]
Maine life sciences sector added 1,700 jobs in past decade
Employment in Maine’s life sciences sector climbed 26% over the past decade, according to report by the Bioscience Association of Maine.
Growing Southern Nevada’s health care economy
Last week The Lincy Institute, the Vegas Chamber, the Vegas Chamber Leadership Foundation, and the Nevada Health and Bioscience Corporation hosted a symposium on the future of Southern Nevada’s health care economy. Today, health care is the fastest-growing sector in the regional economy having added more than 42,000 jobs since 2016. Yet, despite this growth […]
These 'five pillars' for living healthier longer are easy and affordable
Longevity has become a bit of a buzz word, and has become increasingly aligned with the tech industry. But while it remains unclear whether the billions of US dollars being invested in life-extending bioscience is something any of us can access, a timely report from Harvard Medical School reminds us what we can do on our own – and it's backed by a huge body of evidence.
IDEAYA Biosciences Reports Second Quarter 2026 Financial Results and Provides Business Update
Registrational OptimUM-02 trial of the darovasertib combination in metastatic uveal melanoma (mUM) met its primary endpoint; new drug application (NDA) filing...
Colossal Biosciences reportedly in talks to raise new capital at $20B–$30B valuation
The de-extinction startup is looking to double or triple its previous valuation, according to the report.
Morgridge hosts annual science camp for rural high school students
The Morgridge Institute’s Rural Summer Science Camp allows Wisconsin high school students to experiment in the University of Wisconsin-Madison’s world-class bioscience labs.
Scientists call for stewardship practices to be integrated into biodiversity conservation frameworks
A new article in the journal BioScience argues that the stewardship practices of Indigenous Peoples and other place-based knowledge holders have been systematically underrepresented in both conservation ...
GE HealthCare in talks over possible $1 billion deal for Sofie Biosciences, FT reports
GE HealthCare Technologies is in talks over a possible $1 billion deal to buy radiopharmaceutical developer Sofie Biosciences, the Financial Times reported on Sunday citing people familiar with the matter.
UT Health San Antonio scientists honored with BioMedSA Innovation Awards
Two scientists at UT Health San Antonio, the academic health center of The University of Texas at San Antonio (UT San Antonio), will be honored with 2026 BioMedSA Innovation in Healthcare and Bioscience awards. The awards recognize San Antonio leaders in the areas of research, clinical innovation, entrepreneurship and lifetime achievement, whose accomplishments improve lives […]
MBX Biosciences to Provide 2026 Outlook and Business Update at 44th Annual J.P. Morgan Healthcare Conference
One-year follow-up data from Phase 2 trial of once-weekly canvuparatide, a potential best-in-class therapy for hypoparathyroidism, anticipated in Q2 2026; Phase 3 initiation on track for Q3 2026 12-week data from Phase 1 trial of MBX 4291, a dual GLP-1/GIP co-agonist prodrug with potential for once-monthly dosing and improved tolerability for obesity, anticipated in Q4 2026 Nomination of two additional obesity candidates expected in 2026: an amycretin prodrug and a GLP-1/GIP/GCGR triple agonist,
Upcoming opportunities
🔬 Know a scientist whose sustained service to ASBMB and professional accomplishments have advanced the molecular biosciences? Consider nominating them as an ASBMB Fellow.
Ilika, Genflow Biosciences, EnergyPathways, Ariana Resources, Tertiary Minerals, Light Science Technologies - Small Cap Week in Review
Covington Municipal Airport Partners with Air Charter Advisors to Expand Business Aviation Access
Strategic collaboration streamlines on-demand private jet travel for East Atlanta's growing industrial and film production sectors.Covington, Georgia--(Newsfile Corp. - February 26, 2026) - Covington Municipal Airport (KCVC) has announced a formal partnership with Air Charter Advisors to coordinate on-demand private aviation services from its Newton County facility. The agreement strengthens transportation infrastructure for the region's expanding bioscience, advanced manufacturing, and film...
BD Merges Biosciences & Diagnostics Business With Waters
BDX completes its Biosciences & Diagnostic spin-off and Waters merger, securing $4B in proceeds as it pivots to a pure-play MedTech focus.
The Wild League aims to turn sports mascots into conservation champions
Lions, tigers and bears aren’t just among the world’s most iconic wildlife. They’re also among the most popular mascots in professional sports. A new study published in BioScience finds that across 50 countries and 10 team sports, 727 professional organizations use wild animals in their names, logos or fan nicknames. The most frequently represented species […]
Upcoming opportunities
🔬 Know a scientist whose sustained service to ASBMB and professional accomplishments have advanced the molecular biosciences? Consider nominating them as an ASBMB Fellow.
Novartis says Avidity's science could apply beyond muscular dystrophies
Novartis eyes Alzheimer's and Parkinson's as it looks to expand the AOC platform acquired in its $12 billion Avidity Biosciences buyout.
Upcoming opportunities
🔬 Know a scientist whose sustained service to ASBMB and professional accomplishments have advanced the molecular biosciences? Consider nominating them as an ASBMB Fellow.
Phibro Animal Health honored with Governor’s Bioscience Award
Company has maintained a significant presence in Nebraska since acquiring Baltzell Agri Products mineral nutrition business in 2009.
NovaBridge to Host Business Update Call to Review Phase 2a Data for VIS-101 in Wet AMD on Monday, March 9, 2026
VIS-101, purpose-designed to be a best-in-class dual VEGF-A/ANG-2 inhibitor, has the potential to provide more effective and durable treatment than the current standard of care for patients with wet AMD, DME and RVO Visara, a NovaBridge Majority-Owned Subsidiary, Holds Global Rights to VIS-101 Outside of Greater China and Certain Asian Territories ROCKVILLE, Md., March 03, 2026 (GLOBE NEWSWIRE) -- NovaBridge Biosciences (Nasdaq: NBP) (NovaBridge or the Company) a global biotechnology platform co
Anixa Biosciences Appoints UPenn's Dr. Carmen Guerra to Cancer Business Advisory Board
Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced the appointment of Carmen Guerra, M.D., M.S.C.E., F.A.C.P., to its Cancer Business Advisory Board.
Colossal Biosciences' Ben Lamm on AI and the science of de-extinction
Ben Lamm, Colossal Biosciences Co-founder and CEO, told CNBC's Julia Boorstin at the 2026 CNBC AI Forum about how AI helps make "magic" happen when it comes to de-extinction.
Guardant Health Faces a $245 Million Patent Judgment, But Its Newer Tests Could Offer Protection
Guardant Health, Inc. (NASDAQ:GH) faces a costly legal setback after a US court ordered the cancer-testing company to pay more than $245.2 million in a DNA-sequencing patent dispute. The final judgment upheld a 2023 jury verdict finding that Guardant willfully infringed two DNA-sequencing patents asserted by TwinStrand Biosciences and the University of Washington. The financial […]
IDEAYA Biosciences Reports First Quarter 2026 Financial Results and Provides Business Update
Phase 2/3 registrational trial (OptimUM-02) of darovasertib combination met its primary endpoint; complete data will be provided in a late-breaking oral...
Middle, High School Students Given a Spark to Explore Pathway into Science at Mission College
To connect middle and high school students to a possible career in science, El Nido Family Centers partnered with Bioscience Los Angeles County Inc. (Bioscience LA) and LA Mission College […]
UAB opens Shelby Biosciences Research Building to advance health
UAB has opened the Shelby Biosciences Research Building, an eight-story facility named after former U.S. Sen. Richard Shelby, aimed at supporting health research and creating new jobs.
Luma locks down 15-year, $410M fund for life science investments
Luma Group today announced the final close of its inaugural life sciences venture capital fund, totaling $410 million. The New York-based investment firm has had a grip on life sciences since its founding in 2023. The funds unveiled today, dubbed LumaBio Fund I, include investments that have already been made into more than 10 biotechs. They include the likes of eye disease-focused Character Biosciences, rebranded Belgian biotech Coultreon Biopharma and cellular rejuvenation company Altos Labs. The fund saw early success when one of the companies it co-founded, called Vaccine Company, was picked up by Eli Lilly earlier this year for up to $1.55 billion. The acquisition of the in vivo nanoparticle technology-focused biotech formed part of a trio of vaccine buys for the Big Pharma, which has itself been on a prolonged spending spree in 2026. Luma's fund is structured as a 15-year investment with plans to support groundbreaking science and support companies through key milestones from discovery to commercialization, Luma explained in the release. "We founded Luma Group on the belief that extraordinary science, supported by patient, long-term capital, has the power to improve millions of lives," Joshua Fink, founder and managing member of Luma Group, said in the release. "This fund represents more than capital—it is a commitment to partnering with extraordinary innovators as they translate visionary science into life-changing medicines."
Animal health company awarded 2026 Governor’s Bioscience Award
A global animal health company was named the 2026 recipient of the Governor’s Bioscience Award, which recognizes individuals or companies that make significant contributions to Nebraska’s bioscience industry.
The Woolly Mammoth’s Comeback Is Taking Longer Than Expected
Colossal Biosciences now estimates that it will de-extinct a woolly mammoth sometime in the 2030s.
IFF Enters Into Agreement to Sell Its Food Ingredients Business to CVC
IFF (NYSE: IFF), a global leader in flavors, fragrances, food ingredients, and health and biosciences, today announced that it has entered into an agreement to sell its Food Ingredients business to funds advised by CVC Capital Partners, a leading global private markets manager, in a transaction that values the business at approximately $4.3 billion, representing an enterprise value-to-EBITDA multiple of approximately 10x.
Brain implants fuel U.S.-China bioscience rivalry
The devices are bringing new hope to patients with strokes, Parkinson's disease and other neurological conditions.
Biotech firm Colossal set to return extinct bird’s egg to New Zealand
The biotech firm trying to bring extinct species back to life, Colossal Biosciences Inc., will return an egg from the flightless moa to its native New Zealand.
Commission to examine how precision approaches improve healthcare effectiveness, cost-efficiency, equity, and scalability worldwide.
Prof. Michèle Ramsay at the Sydney Brenner Institute for Molecular Bioscience is one of four co-chairs of the Lancet Commission on Precision Health.
Secretive Rampart Bioscience closes after pursuing non-viral gene therapy
Two former employees, who spoke under the condition of anonymity, confirmed that Rampart closed its doors last week after launching with $125 million.